Exercise Study for Leukemia Survivors

Not Applicable

Recruiting

• Conditions: Acute Myeloid Leukaemia; Acute Lymphoblastic Leukaemia; Cancer - Leukaemia - Acute leukaemia

• Registration Number: ACTRN12623001049662
• Lead Sponsor: The Baker Heart and Diabetes Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-27
• Last Update Posted: 3 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Adults with acute leukaemia in complete morphologic remission (CR or CRi)following intensive chemotherapy.
Age greater than or equal to 18 years.
Ability to provide informed consent.
Consent to ALLG NBCR and Alfred Tissue Bank (required for biospecimen collection).
Willingness to attend scheduled appointments and undertake scheduled assessments.

Exclusion Criteria

Patients not being treated with curative intent.
Subjects for whom, in the opinion of the investigator, participation would pose an unnecessary risk to participant or study.
Concurrent malignancy requiring chemotherapy or major illness which, in the opinion of the investigator, may to confound assessments.

Study & Design

• Study Type: Interventional
• Study Design: Not specified